Talvey 40 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FJT93
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,926
Award facts
- Contract value 100% obligated
- $27,926.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,926.36 to AmerisourceBergen Drug Corp for TALVEY 40 mg/ml vials. This firm fixed-price, competitively awarded delivery order (Contract No. 4569329234) was issued on September 4, 2025, with an ultimate completion date of September 25, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial IDC with DLA enables the supply of a vast range of pharmaceutical products and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This specific delivery order for TALVEY—a specialty oncology medication—exemplifies AmerisourceBergen's role in supporting military and federal healthcare requirements through competitively awarded contracts with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DB25FJT93?
SPE2DB25FJT93 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FJT93 worth?
The government has obligated $27,926 on SPE2DB25FJT93.
Is contract SPE2DB25FJT93 an order under another contract?
Yes. SPE2DB25FJT93 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT93 competed?
The extent of competition for SPE2DB25FJT93 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award